SCHEMBL30686756

SCHEMBL30686756

CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)C(C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](NC(=O)CNC(=O)[C@H](N)CCSC)[C@H](C)CC)C(C)C)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCCCN)C(=O)N1CCCC1C(=O)O

nearest known ligand 0.72

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ CALCR P30988 3/20 0.56
▸ RXFP1 Q9HBX9 1/20 0.56
▸ TFPI P10646 4/20 0.55
▸ KEAP1 Q14145 2/20 0.55
▸ NPY2R P49146 3/20 0.54
▸ NPY4R P50391 3/20 0.54
▸ NPY5R Q15761 3/20 0.54
▸ NPY1R P25929 2/20 0.54
▸ GLP1R P43220 1/20 0.54
▸ MAPK8 P45983 1/20 0.53
▸ MAPK9 P45984 1/20 0.53
▸ MAPK10 P53779 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30607307 0.90 OPRM1 (0.57) TFPINPY2RNPY4RNPY5RNPY1R
SCHEMBL30658338 0.89 CALCR (0.63) CALCRKEAP1NPY2RNPY4RNPY5R
SCHEMBL30887555 0.88 CALCR (0.66) CALCRTFPIKEAP1NPY2RNPY4R
SCHEMBL30393126 0.88 OPRM1 (0.50) TFPIKEAP1MAPK8MAPK9MAPK10
SCHEMBL30358175 0.88 CALCR (0.62) CALCRTFPIKEAP1NPY2RNPY4R
SCHEMBL30565140 0.88 CALCR (0.68) CALCRKEAP1GLP1R
SCHEMBL30565138 0.88 CALCR (0.68) CALCRKEAP1GLP1R
SCHEMBL30567755 0.87 NPY2R (0.59) CALCRTFPINPY2RNPY4RNPY5R
SCHEMBL29555982 0.87 OPRM1 (0.50) TFPIKEAP1MAPK8MAPK9MAPK10
SCHEMBL30028547 0.87 CALCR (0.65) CALCRTFPIKEAP1NPY2RNPY4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240374689-A1 HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME LONGEVITY BIOTECH, INC. 2024-11-14 — — US disclosed
US-11851644-B2 Marine bacteria formulation useful in aquaculture UNIVERSITY OF RHODE ISLAND BOARD OF TRUSTEES (US) 2023-12-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240374689-A1 HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME SCTR, GIPR, APLNR CALCR 118/4885RXFP1 111/4885TFPI 1309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback